Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis

Recently, two randomized trials, the PARTNER 3 and the Evolut Low Risk Trial, independently demonstrated that transcatheter aortic valve replacement (TAVR) is non-inferior to surgical aortic valve replacement (SAVR) for the treatment of severe aortic stenosis in patients at low surgical risk, paving...

Descripción completa

Detalles Bibliográficos
Autores principales: Polimeni, Alberto, Sorrentino, Sabato, De Rosa, Salvatore, Spaccarotella, Carmen, Mongiardo, Annalisa, Sabatino, Jolanda, Indolfi, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074202/
https://www.ncbi.nlm.nih.gov/pubmed/32041189
http://dx.doi.org/10.3390/jcm9020439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074202/
https://www.ncbi.nlm.nih.gov/pubmed/32041189
http://dx.doi.org/10.3390/jcm9020439

Ejemplares similares